Copyright
©The Author(s) 2024.
World J Clin Cases. Jul 16, 2024; 12(20): 4397-4404
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4397
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4397
Ref. | Year | Age | BMI (kg/m2) | Parity | History of hypertension | Stage | Thrombosis site | Adjuvant therapy | Status |
Blustein et al[19] | 2023 | 35 | No record | 1 | Yes | IIB | Right MCA | Carboplatin, dose-dense paclitaxel for 6 courses | Survive |
You et al[30] | 2022 | 41 | No record | No record | No record | No record | Left parietal, temporal lob | Neoadjuvant therapy × 3 | Died |
Tandi et al[33] | 2022 | 76 | No record | No record | No | IIA | posterior cortical artery | No record | No record |
Farooqui et al[34] | 2021 | 52 | No record | No record | No | IV | Right MCA and ACA | No record | No record |
Chen et al[21] | 2020 | 46 | 21.8 | No record | Yes | IIIC | Deep vein thrombosis and pulmonary embolism | Carboplatin, paclitaxel for 3 courses | Survive |
Sakuta et al[35] | 2019 | 55 | No record | No record | No | IV | Left MCA | Not yet started | Survive |
Potugari et al[36] | 2019 | 52 | No record | No record | Yes | IIIB | Multiple acute and subacute infarcts in the brain | Neoadjuvant therapy × 6, post-op chemotherapy × 3 | Survive |
Ricci et al[37] | 2018 | 57 | No record | No record | No | No record | Left mesial-occipital lobe | Yes | Survive |
Lin et al[31] | 2015 | 60 | Not record | Not record | Yes | IIIC, recurrent | Bilateral cerebra and cerebella | No | Died |
Yagi et al[38] | 2014 | 54 | No record | No record | No | No record | Right MCA | No | Died 3 weeks after the onset of stroke |
Kuan et al[39] | 2014 | 49 (median of 8810 patients) | No record | No record | Yes (risk factor) | No record | Ischemic stroke risk: 1.38-fold | No record | No record |
Tadokoro et al[40] | 2013 | 55, 56 | No record | No record | No | No record | Left MCA | No record | No record |
Naoi et al[28] | 2013 | 55, 62 | No record | No record | No record, Yes | IIIC, IC | Bilateral thalamus, right frontal lobe, and left cerebellum | Carboplatin, paclitaxel for 6 courses, recurrence | Died, survive |
Devulapalli et al[29] | 2012 | 62 | No record | No record | Yes | I | Occipital | Carboplatin, paclitaxel for 6 courses | Survive |
Oueida et al[32] | 2011 | 56 | Not record | Not record | No | IC | Endocarditis with multi-organ embolic infarction | 5 courses of adjuvant chemotherapy | Died |
Current case | 2024 | 43 | 25.5 | 0 | Yes | IA | Left MCA | Carboplatin, paclitaxel for 6 courses | Survive |
- Citation: Siu WYS, Ding DC. Ischemic stroke with concomitant clear cell carcinoma of the ovary: A case report and review of literature. World J Clin Cases 2024; 12(20): 4397-4404
- URL: https://www.wjgnet.com/2307-8960/full/v12/i20/4397.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i20.4397